(Q33263624)

24 July 2017

Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery (English)

1 reference

24 July 2017

1 reference

F Brunstein

1

1 reference

24 July 2017

J Rens

2

1 reference

24 July 2017

S T van Tiel

3

1 reference

24 July 2017

A M M Eggermont

4

1 reference

24 July 2017

T L M ten Hagen

5

1 reference

24 July 2017

language of work or name

English

0 references

publication date

14 November 2006

1 reference

British Journal of Cancer

24 July 2017

1 reference

24 July 2017

95

1 reference

24 July 2017

1663-1669

1 reference

24 July 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603461

24 July 2017

0 references

cites work

Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Histamine-induced phosphoinositide metabolism in cultured human umbilical vein endothelial cells. Association with thromboxane and prostacyclin release

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

New colorimetric cytotoxicity assay for anticancer-drug screening

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

Inhibition of prostaglandin synthesis in human endothelial cells treated with metabolic inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360755

The role of chemotherapy in the treatment of adult soft tissue sarcomas.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603461

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603461

The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603461

Hyperthermic Isolated Perfusion With Low-Dose Tumor Necrosis Factor α and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue Sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603461

Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study

21 January 2018

1 reference

12 December 2020

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity

1 reference

12 December 2020

Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion

1 reference

12 December 2020

Possible mechanism(s) for permeability recovery of venules during histamine application

1 reference

12 December 2020

Factors that define the susceptibility of endothelial cells to tumor necrosis factor and lipid A

1 reference

12 December 2020

In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion

1 reference

12 December 2020

Localization of 12-hydroxyeicosatetraenoic acid in endothelial cells

1 reference

12 December 2020

Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein

1 reference

12 December 2020

Vascular Endothelium as the Vulnerable Element in Tumours

1 reference

12 December 2020

Incidence of spontaneous tumors in a group of retired breeder female brown Norway rats

1 reference

12 December 2020

Soft tissue limb sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603461

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6603461

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference